ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 88 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $52,000 | -40.2% | 13,547 | -5.5% | 0.00% | – |
| Q4 2019 | $87,000 | -20.2% | 14,331 | -0.8% | 0.00% | – |
| Q3 2019 | $109,000 | -39.1% | 14,451 | +9.3% | 0.00% | -100.0% |
| Q2 2019 | $179,000 | +175.4% | 13,220 | +77.3% | 0.00% | – |
| Q1 2018 | $65,000 | -33.7% | 7,457 | -5.1% | 0.00% | – |
| Q4 2017 | $98,000 | +53.1% | 7,857 | +2.8% | 0.00% | – |
| Q3 2017 | $64,000 | -46.7% | 7,644 | +8.1% | 0.00% | – |
| Q2 2017 | $120,000 | -99.4% | 7,073 | +253.1% | 0.00% | – |
| Q1 2016 | $19,000,000 | – | 2,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |